Company Analysis Penumbra, Inc.
1. Summary
Advantages
- The stock's return over the last year (25.4%) is higher than the sector average (-47.17%).
- The company's current efficiency (ROE=1.2%) is higher than the sector average (ROE=-83.32%)
Disadvantages
- Price (253.4 $) is higher than fair price (5.01 $)
- Dividends (0%) are below the sector average (1.28%).
- Current debt level 14.57% has increased over 5 years from 12.36%.
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
Penumbra, Inc. | Healthcare | Index | |
---|---|---|---|
7 days | -2.1% | -0.4% | 0.5% |
90 days | -8% | -45.3% | 16.1% |
1 year | 25.4% | -47.2% | 10.6% |
PEN vs Sector: Penumbra, Inc. has outperformed the "Healthcare" sector by 72.57% over the past year.
PEN vs Market: Penumbra, Inc. has outperformed the market by 14.75% over the past year.
Stable price: PEN is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: PEN with weekly volatility of 0.4885% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (253.4 $) is higher than the fair price (5.01 $).
Price is higher than fair: The current price (253.4 $) is 98% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (667.49) is higher than that of the sector as a whole (52.65).
P/E vs Market: The company's P/E (667.49) is higher than that of the market as a whole (61.8).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (8.13) is lower than that of the sector as a whole (10.87).
P/BV vs Market: The company's P/BV (8.13) is lower than that of the market as a whole (20.58).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (7.83) is higher than that of the sector as a whole (4.03).
P/S vs Market: The company's P/S indicator (7.83) is lower than that of the market as a whole (15.97).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (186.8) is higher than that of the sector as a whole (16.12).
EV/Ebitda vs Market: The company's EV/Ebitda (186.8) is higher than that of the market as a whole (18.72).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -34.52% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-34.52%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-8.87%).
5.4. ROE
ROE vs Sector: The company's ROE (1.2%) is higher than that of the sector as a whole (-83.32%).
ROE vs Market: The company's ROE (1.2%) is lower than that of the market as a whole (42.63%).
5.5. ROA
ROA vs Sector: The company's ROA (0.9071%) is lower than that of the sector as a whole (6.38%).
ROA vs Market: The company's ROA (0.9071%) is lower than that of the market as a whole (23.26%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (-0.68%) is lower than that of the sector as a whole (15.06%).
ROIC vs Market: The company's ROIC (-0.68%) is lower than that of the market as a whole (9.17%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.28%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription